Breaking News Instant updates and real-time market news.

AMD

AMD

$18.49

-0.29 (-1.54%)

, NVDA

Nvidia

$251.97

1.35 (0.54%)

08:58
08/06/18
08/06
08:58
08/06/18
08:58

AMD price target raised to $25 from $21 at BofA/Merrill

BofA/Merrill analyst Vivek Arya raised his price target on AMD (AMD) to $25 and kept his Buy rating while also raising his FY19 EPS target to 75c vs. consensus view of 62c. The analyst cites AMD's "generational opportunity" to exploit Intel (INTC) 10nm delays to gain market share data security and cloud servers along with its recent upward revision in server average selling prices, as indicated by Mercury industry data. Arya further notes the company's "discussion with several large cloud customers for its second-gen 7nm Rome server, as well as its 7nm computing graphics card for AI, where it competes against NVidia (NVDA).

AMD

AMD

$18.49

-0.29 (-1.54%)

NVDA

Nvidia

$251.97

1.35 (0.54%)

INTC

Intel

$49.32

0.15 (0.31%)

  • 07

    Aug

  • 14

    Aug

  • 16

    Aug

  • 16

    Aug

  • 28

    Aug

AMD AMD
$18.49

-0.29 (-1.54%)

07/27/18
ARGS
07/27/18
NO CHANGE
Target $23
ARGS
Buy
AMD price target raised to $23 from $18 at Argus
Argus analyst Jim Kelleher raised his price target on AMD to $23 and kept his Buy rating after its Q2 earnings beat and outlook for high-double-digit annual revenue growth. The analyst cites the strong performance of AMD's Epyc server chip generating growth in the Enterprise, Embedded and Semi-Custom business, while also noting the increasing adoption of its Ryzen chip in the compute business. Kelleher further points to Radeon GPUs experiencing strong demand "despite a cooling in the crypto frenzy."
07/27/18
JEFF
07/27/18
NO CHANGE
Target $44
JEFF
Underperform
Intel model 'showing signs of stress' despite beat, says Jefferies
While Intel (INTC) last night "beat and raised handily" for the second quarter in a row, the model is "showing signs of stress," Jefferies analyst Mark Lipacis tells investors in a post-earnings research note. The analyst highlights declining gross margins, free cash flow well below earnings, and Increasing competition from Nvidia (NVDA), AMD (AMD) "and perhaps even its own customers." Delays in Intel's 10nm product ramp and process node transitions may translate to a disadvantage to AMD in servers in the second half of 2019, Lipacis contends. He reiterates an Underperform rating on Intel and bumped up his price target for the shares to $44 from $42.
07/30/18
COWN
07/30/18
NO CHANGE
Target $25
COWN
Outperform
AMD price target raised to $25 following management meetings at Cowen
Cowen analyst Matthew Ramsay raised his price target on AMD to $25 from $21 following meetings with management. The analyst noted the company posted strong Q2 results, but management's message was the company was just getting started. He said management is determined to capitalize on share gain opportunities in datacenter and client markets. Ramsay reiterated his Outperform rating on AMD shares.
08/06/18
LEHM
08/06/18
NO CHANGE
Target $15
LEHM
Underweight
AMD price target raised to $15 from $9 at Barclays
Barclays analyst Blayne Curtis raised his price target for (AMD) to $15 from $9 but keeps an Underweight rating on the name. The stock closed Friday down 30c to $18.49. The analyst this morning also downgraded his rating on Intel (INTC) to Equal Weight from Overweight. Curtis is now using a higher multiple for AMD to reflect a wider range of outcomes for traction of its Epyc server. The analyst, however, says he has not seen any evidence to support these more bullish levels. Clearly the market is much more optimistic on AMD's growth prospects as reflected in the stock's appreciation, Curtis tells investors in a research note. AMD has effectively reduced the discussion of future server performance to process technology but the lack of response from Intel following the multiple 10nm push-outs leaves little reason for investors to believe differently, Curtis writes.
NVDA Nvidia
$251.97

1.35 (0.54%)

07/23/18
MSCO
07/23/18
NO CHANGE
MSCO
Tariff uncertainty a potential risk to semiconductor demand, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said the firm's quarterly survey of distributors leads him to expect "solid" Q2 results and Q3 guidance from broad-based semiconductor companies this earnings season as demand remains strong. However, the present tariff related uncertainty present a risk for a "demand shock" that could lead to an inventory unwind in the semi supply chain, Moore warns investors. He thinks the potential of further semi stock outperformance is limited at this stage of the cycle, while "even the slightest whiff on the demand front" could lead to a significant decline in stocks, he tells investors. Moore added that he favors companies with more defensive characteristics, such as Analog Devices (ADI), over those with more commodity exposure and lower margins, like Cypress Semiconductor (CY). Other publicly traded companies in the semiconductors space include Micron (MU), AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), Nvidia (NVDA), Qualcomm (QCOM) and Texas Instruments (TXN). Shares of Micron are down 2.5% in pre-market trading to $53.65.
07/18/18
07/18/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MACQUARIE CUTS TWITTER TO NEUTRAL: Macquarie analyst Benjamin Schachter downgraded Twitter (TWTR) to Neutral from Outperform, citing concerns about MAU trends, what he views as a limited set of near-term catalysts, and a valuation he believes will likely limit upside from current levels. GOLDMAN SAYS SELL CLOROX: Goldman Sachs analyst Jason English downgraded Clorox (CLX) to Sell from Neutral and cut his price target for the shares to $112 from $127. The analyst reduced his estimates for the company to reflect a combination of a lower volume forecast, lower gross margin expectation and renewed currency headwinds. English sees an "unsustainably high relative valuation" for Clorox. PIPER RAISES AMAZON TARGET: Piper Jaffray analyst Michael Olson raised his price target on Amazon.com (AMZN) to $2,075 from $1,850 and kept his Overweight rating ahead of its Q2 results. Olson noted that his search index suggests that unit growth will be up 19% -- in line with Q1 and just below consensus for the online segment. The analyst added, however, that his CIO survey suggests intentions to accelerate spending, stating that the AWS segment and other segment revenue is likely to post an upside. Olson is positive on the Amazon stock amid a "plethora of topline tailwinds and potential return to margin expansion" in the second half of this year. CITI SAYS NVIDIA COULD SELL OFF: Citi analyst Atif Malik said his recent supply chain checks indicate discrete graphics gaming demand is expected to remain sluggish thru the September quarter, and believes Nvidia (NVDA) could selloff in the near-term on weaker than expected graphics commentary. Malik, however, kept a Buy rating on Nvidia with a $300 price target, believing his long-term thesis on the shares remains intact. COMERICA UP TO OUTPERFORM: Evercore ISI analyst John Pancari upgraded Comerica (CMA) to Outperform from In Line and increased his price target to $107 from $97 following the Q2 report. Pancari said he expects earnings growth to outpace peers while returns continue to strengthen, supported by a favorable positioning for higher short-term rates, ongoing efficiency improvement, and intact credit.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
INTC Intel
$49.32

0.15 (0.31%)

08/06/18
LEHM
08/06/18
DOWNGRADE
Target $53
LEHM
Equal Weight
Intel downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Blayne Curtis downgraded Intel to Equal Weight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom.
08/06/18
LEHM
08/06/18
DOWNGRADE
Target $53
LEHM
Equal Weight
Barclays downgrades Intel to Equal Weight amid intensifying margin pressure
Barclays analyst Blayne Curtis downgraded Intel to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. With both the server and personal computer markets outperforming, the debate on Intel shares has shifted to the competitive implications of the slippage in the company's process technology, Curtis tells investors in a research note titled "Hard to Defend in a Vacuum." Intel continues to believe that it can retain a performance advantage even with a process node disadvantage, but has provided little evidence to support this, the analyst adds. He believes this creates an "overhang well into 2019." Further, Curtis notes Intel's margin pressure will intensify next year. It is hard for the "stock to work" until the bottoms in margins is clearer, Curtis writes.
07/31/18
DZBN
07/31/18
UPGRADE
DZBN
Buy
Intel upgraded to Buy from Hold at DZ Bank

TODAY'S FREE FLY STORIES

03:50
03/20/19
03/20
03:50
03/20/19
03:50
General news
FX Update: The dollar has been trading steady-to-firmer »

FX Update: The dollar…

CREE

Cree

$57.27

0.36 (0.63%)

03:42
03/20/19
03/20
03:42
03/20/19
03:42
Upgrade
Cree rating change  »

Cree upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

NOMD

Nomad Foods

$20.82

-0.63 (-2.94%)

03:27
03/20/19
03/20
03:27
03/20/19
03:27
Syndicate
Nomad Foods 17.39M share Secondary priced at $20.00 »

The deal size was reduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

CDAY

Ceridian

$50.75

0.94 (1.89%)

03:26
03/20/19
03/20
03:26
03/20/19
03:26
Syndicate
Ceridian 13M share Secondary priced at $50.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 20

    Mar

ATTO

Atento

$3.95

0.06 (1.54%)

20:51
03/19/19
03/19
20:51
03/19/19
20:51
Earnings
Atento reports Q4 recurring EPS 21c, consensus 17c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

TRHC

Tabula Rasa HealthCare

$60.28

1.35 (2.29%)

20:47
03/19/19
03/19
20:47
03/19/19
20:47
Recommendations
Tabula Rasa HealthCare analyst commentary at Piper Jaffray »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

GIS

General Mills

$47.24

-0.365 (-0.77%)

20:25
03/19/19
03/19
20:25
03/19/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

TRN

Trinity Industries

$22.46

-0.25 (-1.10%)

20:20
03/19/19
03/19
20:20
03/19/19
20:20
Hot Stocks
Trinity Industries names Leldon Echols chairman of the board »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

TIGR

UP Fintech

$0.00

(0.00%)

20:06
03/19/19
03/19
20:06
03/19/19
20:06
Syndicate
UP Fintech 13M share IPO priced at $8.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

SND

Smart Sand

$4.27

-0.4 (-8.57%)

20:01
03/19/19
03/19
20:01
03/19/19
20:01
Initiation
Smart Sand initiated at B. Riley FBR »

Smart Sand initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$0.00

(0.00%)

20:00
03/19/19
03/19
20:00
03/19/19
20:00
Initiation
Lyft initiated at DA Davidson »

Lyft initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

DERM

Dermira

$14.13

1.52 (12.05%)

19:40
03/19/19
03/19
19:40
03/19/19
19:40
Syndicate
Dermira 9.8M share Secondary priced at $13.25 per share »

Citi, Cowen, Cantor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

19:38
03/19/19
03/19
19:38
03/19/19
19:38
Upgrade
Nevro rating change at BMO Capital »

Nevro upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

TORC

ResTORbio

$7.16

-1.81 (-20.18%)

19:34
03/19/19
03/19
19:34
03/19/19
19:34
Syndicate
ResTORbio 7.2M share Secondary priced at $6.95 »

BofA/Merrill, SVB Leerink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

19:33
03/19/19
03/19
19:33
03/19/19
19:33
Upgrade
Nevro rating change at BMO Capital »

Nevro upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

PFE

Pfizer

$42.32

0.51 (1.22%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

19:17
03/19/19
03/19
19:17
03/19/19
19:17
Hot Stocks
Pfizer, Merck KGaA discontinue Phase III JAVELIN Ovarian PARP study »

Merck KGaA (MKGAY) and…

PFE

Pfizer

$42.32

0.51 (1.22%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 30

    Apr

  • 18

    May

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

, GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

19:11
03/19/19
03/19
19:11
03/19/19
19:11
Hot Stocks
Google outlines changes to Android mobile options, ad formats in Europe »

Google said in a blog…

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

, GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

19:08
03/19/19
03/19
19:08
03/19/19
19:08
Periodicals
Google offers Android, product ad concessions for Europe, WSJ says »

Google intends to ask all…

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

, SCS

Steelcase

$17.49

-0.115 (-0.65%)

19:06
03/19/19
03/19
19:06
03/19/19
19:06
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

SCS

Steelcase

$17.49

-0.115 (-0.65%)

AUPH

Aurinia Pharmaceuticals

$6.40

0.13 (2.07%)

NVRO

Nevro

$44.76

0.37 (0.83%)

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

TME

Tencent Music

$18.65

-0.48 (-2.51%)

WPRT

Westport

$1.50

(0.00%)

AIR

AAR Corp.

$35.10

(0.00%)

FDX

FedEx

$181.50

-0.92 (-0.50%)

FNV

Franco-Nevada

$75.64

0.035 (0.05%)

PRNB

Principia Biopharma

$36.88

0.48 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 01

    Apr

  • 02

    Apr

  • 05

    Apr

  • 14

    May

  • 28

    May

  • 24

    Jun

  • 26

    Jun

LGIH

LGI Homes

$54.89

-2.27 (-3.97%)

19:02
03/19/19
03/19
19:02
03/19/19
19:02
Hot Stocks
LGI Homes announces new community in Las Vegas »

LGI Homes, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

19:01
03/19/19
03/19
19:01
03/19/19
19:01
Hot Stocks
Sage says Zulresso approval represents 'game-changing approach' to PPD »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

QTRX

Quanterix

$24.59

-0.01 (-0.04%)

18:55
03/19/19
03/19
18:55
03/19/19
18:55
Syndicate
Breaking Syndicate news story on Quanterix »

Quanterix files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIHS

Senmiao Technology

$4.71

-0.275 (-5.52%)

18:55
03/19/19
03/19
18:55
03/19/19
18:55
Syndicate
Breaking Syndicate news story on Senmiao Technology »

Senmiao Technology files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

18:54
03/19/19
03/19
18:54
03/19/19
18:54
Syndicate
Breaking Syndicate news story on Invitation Homes »

Invitation Homes files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

PULM

Pulmatrix

$1.70

-0.09 (-5.03%)

18:53
03/19/19
03/19
18:53
03/19/19
18:53
Syndicate
Breaking Syndicate news story on Pulmatrix »

Pulmatrix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.